Treating cancer with Ecstasy?
Written by: QMI AgencyAug. 21, 2011
Long associated with club culture, the designer drug known as Ecstasy is known to induce euphoria in users for several hours, and in some cases, has resulted in death.
But, new research shows that a modified form of the drug has 100 times more cancer-busting properties than the popular designer drug itself. And scientists at the University of Birmingham say they hope to redesign it to treat leukemia, lymphoma and myeloma.
The study, published online in the journal, Investigational New Drugs, builds on the scientists’ discovery six years ago that revealed that ecstasy and anti-depressants such as Prozac had the potential to stop cancers growing.
At the time, the team stressed that translating their findings into a usable clinical compound would present significant problems, mainly because the dose of MDMA - the scientific name for Ecstasy - required to treat a cancerous tumour would have proved fatal to the patient. So, they began working towards breaking down the actions of the drug to isolate its cancer-killing properties from its general toxicity.On the university's website, lead author professor John Gordon, said, "This is an exciting next step towards using a modified form of MDMA to help people suffering from blood cancer. While we would not wish to give people false hope, the results of this research hold the potential for improvement in treatments in years to come."
No comments:
Post a Comment